| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
8,323 |
5,938 |
$813K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
6,217 |
5,325 |
$396K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
1,801 |
924 |
$393K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
4,249 |
2,668 |
$352K |
| 80053 |
Comprehensive metabolic panel |
16,138 |
10,982 |
$189K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,284 |
885 |
$158K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
1,501 |
1,409 |
$63K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
2,619 |
1,264 |
$21K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
458 |
404 |
$19K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
268 |
233 |
$19K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
865 |
822 |
$16K |
| 71046 |
Radiologic examination, chest; 2 views |
1,489 |
1,273 |
$13K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
721 |
519 |
$13K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
5,490 |
3,502 |
$12K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,093 |
10,544 |
$10K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,879 |
3,078 |
$10K |
| G0378 |
Hospital observation service, per hour |
90 |
72 |
$9K |
| 80050 |
General health panel |
219 |
218 |
$8K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,449 |
2,537 |
$8K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
40 |
39 |
$6K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,335 |
2,680 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
4,098 |
2,490 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,617 |
2,625 |
$6K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
30 |
24 |
$5K |
| 87428 |
|
1,038 |
689 |
$5K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
77 |
27 |
$4K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
820 |
725 |
$4K |
| 71045 |
Radiologic examination, chest; single view |
4,144 |
2,757 |
$4K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
1,812 |
1,279 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,402 |
1,685 |
$2K |
| 87088 |
|
1,944 |
1,460 |
$2K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
2,311 |
1,139 |
$2K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
585 |
444 |
$2K |
| 85610 |
|
1,734 |
1,222 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
315 |
168 |
$2K |
| 87400 |
|
738 |
530 |
$2K |
| 80061 |
Lipid panel |
3,313 |
2,862 |
$2K |
| 83880 |
|
655 |
434 |
$1K |
| 87077 |
|
855 |
653 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,926 |
2,454 |
$1K |
| 84484 |
|
4,344 |
2,426 |
$955.54 |
| 36415 |
Collection of venous blood by venipuncture |
9,847 |
7,789 |
$861.12 |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
576 |
482 |
$817.56 |
| 83690 |
|
4,533 |
2,783 |
$801.39 |
| 73562 |
|
65 |
51 |
$783.08 |
| 83735 |
|
4,212 |
2,571 |
$750.26 |
| 73630 |
|
47 |
44 |
$741.56 |
| 82607 |
|
483 |
432 |
$740.91 |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
223 |
184 |
$708.58 |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
90 |
41 |
$696.37 |
| 81001 |
|
4,845 |
3,352 |
$506.31 |
| 83605 |
|
1,988 |
971 |
$497.50 |
| 96376 |
|
142 |
82 |
$427.41 |
| 85027 |
|
1,687 |
1,280 |
$403.82 |
| 81003 |
|
2,538 |
1,734 |
$382.26 |
| 81025 |
|
743 |
493 |
$360.60 |
| J2274 |
Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
66 |
52 |
$333.80 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
2,621 |
1,329 |
$309.21 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
862 |
430 |
$289.71 |
| 84703 |
|
1,256 |
880 |
$239.54 |
| 73030 |
|
27 |
24 |
$207.66 |
| 87186 |
|
1,021 |
794 |
$153.14 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
1,834 |
1,066 |
$150.69 |
| J2704 |
Injection, propofol, 10 mg |
1,077 |
547 |
$131.00 |
| 87081 |
|
641 |
416 |
$117.31 |
| 86140 |
|
560 |
420 |
$90.48 |
| 84702 |
|
23 |
12 |
$65.27 |
| 84439 |
|
1,959 |
1,600 |
$64.23 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,141 |
575 |
$59.14 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
75 |
57 |
$58.17 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
316 |
176 |
$51.87 |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
14 |
14 |
$48.12 |
| 83550 |
|
58 |
43 |
$40.09 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
566 |
308 |
$37.28 |
| 82550 |
|
93 |
71 |
$36.40 |
| 82746 |
|
313 |
289 |
$31.40 |
| 82728 |
|
51 |
39 |
$23.28 |
| 94760 |
|
162 |
136 |
$19.44 |
| 85652 |
|
639 |
500 |
$17.04 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
219 |
139 |
$16.40 |
| 86850 |
|
63 |
43 |
$16.35 |
| 87040 |
|
67 |
40 |
$12.88 |
| J2060 |
Injection, lorazepam, 2 mg |
361 |
200 |
$11.39 |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
15 |
13 |
$9.55 |
| 94761 |
|
113 |
96 |
$9.02 |
| 85730 |
|
155 |
119 |
$8.20 |
| 87420 |
|
14 |
14 |
$8.18 |
| 82962 |
|
180 |
99 |
$6.46 |
| 86901 |
|
128 |
91 |
$2.04 |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
759 |
340 |
$1.76 |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
103 |
88 |
$1.30 |
| 36416 |
|
176 |
122 |
$0.00 |
| 86592 |
|
39 |
28 |
$0.00 |
| 82043 |
|
60 |
54 |
$0.00 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
52 |
14 |
$0.00 |
| 80320 |
|
91 |
68 |
$0.00 |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
52 |
24 |
$0.00 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
51 |
24 |
$0.00 |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
31 |
24 |
$0.00 |
| 86900 |
|
63 |
43 |
$0.00 |
| 83540 |
|
86 |
69 |
$0.00 |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
140 |
87 |
$0.00 |
| 85007 |
|
41 |
37 |
$0.00 |
| 82570 |
|
99 |
81 |
$0.00 |
| J1171 |
Injection, hydromorphone, 0.1 mg |
14 |
13 |
$0.00 |